Discovering AFF1: A Potential Drug Target for Psychiatric Disorders

Target Name: AFF1

NCBI ID: G4299

AFF1

Discovering AFF1: A Potential Drug Target for Psychiatric Disorders

AFF1, also known as AF4/FMR2 family member 1, is a protein that is expressed in various tissues throughout the body. It is a member of the AFF1 gene family, which is known for its role in the development and maintenance of tissues such as the brain, heart, and nervous system.

One of the unique aspects of AFF1 is its ability to interact with several different proteins, including the neurotransmitter dopamine. This interaction between AFF1 and dopamine has led to the hypothesis that AFF1 may be a drug target or biomarker for the treatment of various psychiatric and neurological disorders.

In addition to its role in neurotransmission, AFF1 has also been shown to play a role in the development and progression of certain diseases, including cancer. For example, studies have shown that high levels of AFF1 are associated with an increased risk of neurobladder cancer, as well as with poor prognosis in patients with pancreatic cancer.

The discovery of AFF1 as a potential drug target or biomarker has important implications for the treatment of psychiatric and neurological disorders. By targeting AFF1 with small molecules or other compounds, researchers may be able to develop new treatments for conditions such as depression, anxiety, and Alzheimer's disease.

In addition to its potential as a drug target or biomarker, AFF1 also has important functions in the body that are not yet fully understood. For example, studies have shown that AFF1 is involved in the regulation of cell death, as well as in the development and maintenance of certain tissues.

Overall, the discovery of AFF1 as a potential drug target or biomarker has significant implications for the treatment of psychiatric and neurological disorders. Further research is needed to fully understand its role and potential as a therapeutic target.

Protein Name: ALF Transcription Elongation Factor 1

The "AFF1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about AFF1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets